Figure 2.
Bayesian response-adaptive design: Schematics of two possible scenarios of response-adaptive randomizations to dose groups.
Panel A: Scenario 1. A best dose is found during Stage 1 and that dose is compared to the control dose in Stage 2.
Panel B: Scenario 2. Stage 1 dose-finding continues to the end of the trial with no best dose identified.